To: gcrispin who wrote (49511 ) 9/25/2012 4:05:29 PM From: gcrispin Respond to of 78752 Since my position and interest in PESI generated some discussion, I thought I would both add and respond to some comments. Yes, this is a real company. Yes, the margins are slim. But I like to use the perspective from Nasdaq and where we look at the income statement over time. As you can see from the link, the income statement is lumpy but there is a year over year progression of it getting better. http://www.nasdaq.com/symbol/pesi/financials?query=income-statement Here is another way to compare the sector. nasdaq.com As an overview I will refer to a Crystal Equity Research piece on the company. http://seekingalpha.com/article/719641-perma-fix-innovator-in-hazardous-materials The take-aways for me is that you have a rather mundane and reasonably priced company that holds significant licenses, and patents. If their novel approach for TC-99 works out, you will have a dramatic expansion of the multiples as one will look at this as also a medical company. Below is another link to an article addressing the issue of a safer way to obtaining this isotope. http://www.nti.org/analysis/articles/what-doctor-ordered-eliminating-weapons-grade-uranium-medical-isotope-production/ As an aside, one of the reasons Iran claims they need enriched uranium is so that they can isolate medical isotopes. One of the impediments for the industry is that there have been problems at the Handford site with the DOE that has slowed processeing down. The CEO refers to this issue is the last CC, and the WSJ recently had an article about it. http://online.wsj.com/article/SB10000872396390443819404577635700925553724.html?KEYWORDS=Hanford+site If their new technology for the creation of TC-99 doesn’t work out, you still have a reasonably priced stock. In that scenario, PESI could be more valuable as a takeover target than as a company. Regardless, this a a dollar stock so obviously the market is assessing a high degree of risk and/or disinterest. However, I believe that there are certain catalysts--specifically the work to eliminate highly enriched uranium in medical isotope production--that makes this a speculative situation that is worth my investment.